Insulin Release Dynamics from Poly(diethylaminoethyl methacrylate) Hydrogel Systems

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Drug Delivery Systems

Background:

• Current insulin delivery methods for type 1 diabetes require frequent monitoring and manual adjustments.
• Development of intelligent drug delivery systems that respond to physiological cues is a key area of research.
• Glucose-sensitive polymers offer a potential platform for automated insulin release.

Purpose of the Study:

• To develop novel glucose-sensitive micro-particles and nanoparticles for automated insulin delivery.
• To investigate the influence of polymer composition and loading conditions on insulin loading and release kinetics.
• To evaluate the potential of these systems for managing type 1 diabetes.

Main Methods:

• Synthesis of poly(diethylaminoethyl methacrylate) (PDEAEM) micro-particles and nanoparticles.
• Decoration of particles with glucose oxidase and catalase enzymes.
• Optimization of insulin loading conditions (pH, particle-to-insulin ratio, concentration).
• Evaluation of insulin release profiles in response to pH and glucose stimuli.
• Characterization of particle size and crosslinking density effects on release.

Main Results:

• Optimal insulin loading achieved at pH 5.6, with a 7:1 particle-to-insulin ratio, and 1.0 mg/mL insulin concentration.
• Microparticles demonstrated both pH-responsive and glucose-responsive insulin release.
• Lower crosslinking ratios (3%) resulted in significantly higher insulin release (nearly 70%) compared to higher ratios (10%, ~33%) after a single stimulus.
• 150 µm PDEAEM micro-particles showed potential for automated insulin delivery.

Conclusions:

• Glucose-sensitive PDEAEM micro-particles decorated with enzymes can effectively load and release insulin in response to stimuli.
• Particle crosslinking density critically influences insulin release rates.
• These smart micro-particles represent a promising approach for developing automated insulin delivery systems for type 1 diabetes management.